EvalueLogix/ Reva
Manage and evaluate patients considered for Biologic therapy in the treatment of RA, JIA and PsA.
To assist with the evaluation of patients considered for Biologic therapy in the treatment of RA, JIA and PsA the EvalueLogix application has been developed from processes currently in use within the NHS.
The system provides for the recording, calculation, analysis and graphing of a number of Rheumatology Assessments and Evaluation Tools including:
-
BASDAI, HAQ, CHAQ, EUROQOL, DAS, PsARC, ACRJIA
Results of the assessments can be updated and calculated with full audit trail against each element. The Consultant can schedule visits and enter say, NICE parameters for Threshold and Visit to Visit Comparisons; the system will then evaluate and highlight these parameters and comments against the results from each visit. At the end of each patient visit a clinic letter can be produced with the relevant information and clinician comments.
EvalueLogix users also have access to Reva, an online database of aggregate data from all EvalueLogix users, offering sophisticated drug performance analysis and benchmarking against selected organisations.
EvalueLogix is made commercially available by EPS through NHS Innovations South East.

Example screen for Rheumatoid Arthritis assessment.
Comparitive analysis of DAS scores over time for two groups of patients, using the aggregate data available in Reva.